Wolverine Trading’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-21,100
Closed -$6.73K 5473
2023
Q4
$6.73K Sell
21,100
-4,800
-19% -$1.24K ﹤0.01% 4412
2023
Q3
$6.99K Sell
25,900
-7,800
-23% -$2.83K ﹤0.01% 4374
2023
Q2
$16.5K Buy
33,700
+4,500
+15% +$2.69K ﹤0.01% 4108
2023
Q1
$18K Sell
29,200
-87,200
-75% -$59.1K ﹤0.01% 4022
2022
Q4
$40K Buy
116,400
+24,300
+26% +$9.88K ﹤0.01% 3624
2022
Q3
$42K Buy
92,100
+4,300
+5% +$2.24K ﹤0.01% 4202
2022
Q2
$37K Sell
87,800
-7,900
-8% -$3.52K ﹤0.01% 4138
2022
Q1
$60K Sell
95,700
-27,300
-22% -$21K ﹤0.01% 5026
2021
Q4
$133K Sell
123,000
-8,800
-7% -$13.6K ﹤0.01% 4958
2021
Q3
$229K Sell
131,800
-139,400
-51% -$313K ﹤0.01% 5130
2021
Q2
$876K Buy
271,200
+800
+0.3% +$2K ﹤0.01% 2946
2021
Q1
$930K Buy
270,400
+192,500
+247% +$697K ﹤0.01% 2849
2020
Q4
$48K Sell
77,900
-61,500
-44% -$28.1K ﹤0.01% 4613
2020
Q3
$49K Sell
139,400
-17,700
-11% -$6.85K ﹤0.01% 4279
2020
Q2
$90K Buy
157,100
+110,900
+240% +$53.5K ﹤0.01% 4177
2020
Q1
$17K Sell
46,200
-24,400
-35% -$25.5K ﹤0.01% 4441
2019
Q4
$100K Buy
70,600
+65,015
+1,164% +$226K ﹤0.01% 4279
2019
Q3
$45K Sell
5,585
-1,584
-22% -$21.5K ﹤0.01% 4067
2019
Q2
$127K Sell
7,169
-7,646
-52% -$167K ﹤0.01% 3923
2019
Q1
$458K Sell
14,815
-6,370
-30% -$213K ﹤0.01% 2883
2018
Q4
$675K Buy
21,185
+1,754
+9% +$79.7K ﹤0.01% 2351
2018
Q3
$1.47M Buy
19,431
+8,631
+80% +$584K ﹤0.01% 1958
2018
Q2
$239K Hold
10,800
﹤0.01% 4126
2018
Q1
$239K Buy
10,800
+1,808
+20% +$41.4K ﹤0.01% 4126
2017
Q4
$226K Buy
8,992
+6,800
+310% +$209K ﹤0.01% 3995
2017
Q3
$41K Buy
+2,192
New +$25.5K ﹤0.01% 4260
2017
Q1
Sell
-915
Closed -$15K 5185
2016
Q4
$15K Sell
915
-4,347
-83% -$89.1K ﹤0.01% 4332
2016
Q3
$111K Sell
5,262
-2,269
-30% -$41.5K ﹤0.01% 4140
2016
Q2
$129K Buy
+7,531
New +$236K ﹤0.01% 3531

Other funds holding ASXC

Wolverine Trading's ASXC Position: Q4 2022 in Review

Wolverine Trading sold out of Asensus Surgical, Inc. (ASXC) in Q4 2022, closing a stake of 99,554 shares — an estimated $40.5K sold.

Wolverine Trading first reported a position in ASXC in Q2 2016 and held it in 22 quarters. The position peaked at $261K in Q3 2018. 74 funds tracked by Wall St. Rank hold ASXC as of Q4 2022.

  • Wolverine Trading reported no remaining Asensus Surgical, Inc. position as of Q4 2022 after selling out during the quarter.
  • Wolverine Trading sold 99,554 Asensus Surgical, Inc. shares in Q4 2022, an estimated $40.5K.
  • Wolverine Trading first reported a position in Asensus Surgical, Inc. in Q2 2016 and held it in 22 quarters.
  • Wolverine Trading's Asensus Surgical, Inc. position peaked at $261K in Q3 2018.
  • 74 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.